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PROCALCITONIN AS A MARKER OF SEPSIS IN 
HOSPITALISED ELDERLY 
INTRODUCTION 
          Sepsis is a systemic inflammatory response secondary to an acute 
infection. The incidence of sepsis and mortality due to it has increased, 
particularly in older adults above 60yrs of age and is one of the leading 
cause of mortality in them. More than 50% of the population with severe 
sepsis is over 65 yrs old. Since there is a worldwide increase in aging 
population, the incidence of sepsis is also expected to raise. 
          Due to decline in immune function observed generally in elderly 
patients results in atypical and mostly subtle (e.g.mild fever or even 
apyrexia) clinical presentation of sepsis and  bacteremia, Atypical 
symptoms and presentation in elderly can lead to difficulty in clinically 
diagnosing sepsis, leading to a delay in diagnosis and initiation of therapy 
resulting in higher mortality.  
          The early detection of patients with sepsis with poor prognosis or 
with an increased risk of mortality is very important in order to prevent 
subsequent organ dysfunction, which further increases the degree of 
complications and thereby mortality. Hence there is an obvious need for 
biomarkers of inflammation to detect bacterial infections in patients with 
sepsis. 
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          Parameters other than infection may influence the conventional 
markers of inflammation and they may be slowly released during the 
progression of an infection. Bacteriological reports will not be available 
before 24 to 48 hours.Moreover positive reports may be due to 
contamination and negative reports will not exclude sepsis            
Procalcitonin tends to increase earlier upon infection with a very rapid 
decline in serum level when the infection is controlled. Moreover the 
production of procalcitonin, unlike other biomarkers including C-reactive 
protein(CRP), seems not to be significantly weakened by non-steroidal 
and steroidal anti-inflammatory drugs. Estimation of serum procalcitonin 
level may be helpful in diagnosing and treating sepsis at the earliest. 
           Procalcitonin levels tend to increase with organ dysfunction and 
increase in severity of sepsis, Furthermore, administration of 
procalcitonin to septic animals had shown to increase their mortality risk, 
thereby indicating a relationship between increased serum procalcitonin 
and death. The serum procalcitonin levels may aid in earlier identification 
and better stratification of septic  patients with increased  risk of death: 
    However the relation of serum procalcitonin level with  the prognosis 
of sepsis is unclear. Inaddition to that  the usefulness of bio markers such 
as procalcitonin in elderly population has not been studied adequately, as 
most of the previous studies included either adult or paediatric 
population, necessiating the need for further studies in elderly population 
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AIM 
 
 To estimate the significance of procalcitonin as a biomarker in 
the diagnosis of sepsis in elderly patients  
 
 To estimate the role of procalcitonin in the prognosis of sepsis in 
elderly and to compare it with conventional markers of sepsis 
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REVIEW OF LITERATURE 
Sepsis is a syndrome of biochemical, physiologic and pathologic 
abnormalities caused by  dysregulated host response to infection leading 
to organ dysfunction28. It is a life threatening condition, that arises when 
the body’s response to an infection injures its own tissue and organs. It is 
of major public health interest. Sepsis is common in elderly, critically ill 
and immune compromised patients. Incidence of sepsis is increasing, 
likely due to increase in aging population with more co-morbidities. 
Sepsis is a leading cause of critical illness and mortality worldwide1,2. 
Septic shock is a subset of sepsis in which underlying circulating 
and cellular metabolism abnormalities are profound enough to 
substantially increase mortality. Patients with septic shock can be 
identified with a clinical construct of sepsis with persisting hypotension 
requiring vasopressors to maintain MAP ≥ 65mm of Hg and having a 
serum lactate level > 2mmol/L despite adequate volume resuscitation. 
When microorganisms penetrates the epithelial barriers, entering 
the underlying tissues of living organisms, they mount local and systemic 
response to those microbes. 
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The cardinal presen 
tations of the systemic responses are 
1) Increase or decrease in body temperature (hyper or 
hyperthermia) 
2) Increase or decrease in WBC count (leukocytosis or 
leukopenia) 
3) Increase in respiratory rate (tachypnoea) 
4) Increase in heart rate (tachycardia)  
         This response can be harmful, and can also occur in response to 
trauma, surgery burns and other major stresses. When this response leads 
to hypofunction or deteriorating function of an organ, which is not 
infected and an infectious cause is suspected or proved to be responsible 
for the systemic response, it can be described as sepsis. 
        When sepsis is associated with fall in blood pressure (hypotension) 
which is not corrected by intravenous fluids infusion then septic shock 
should be suspected.  
Definitions to describe Septic Patients (Harrison’s) 
Bacteremia:  
         Presence of bacteria in the blood of patient, as evidenced by 
positive blood cultures. 
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Signs of possibly harmful systemic response: 
          Presence of 2 or more of the following conditions 
1. Fever (oral temperature >380C / >100.40F) or hypothermia(<360C / 
<96.80F) 
2. Tachypnea (>24 breaths/min) 
3. Tachycardia(Heart Rate >90 beats/min) 
4. Leukocytosis(>12,000/microlitre), leukopenia(<4000/microlitre) or 
>10% bands 
SEPSIS (or Severe Sepsis): 
The presence of harmful systemic response to proven or suspected 
infection with some degree of organ hypofunction i.e. 
1. Cardiovascular : Arterial systolic BP  <90mmHg or MAP < 
70mmHg that responds to administration of fluids 
2. Renal : Urine output < 0.5ml / kg per hr for 1 hr despite adequate 
fluid resuscitatiom 
3. Respiratory : PaO2 / FiO2 < 250 or < 200, if the lung is the only 
dysfunctional organ 
4. Hematologic : Platelet count < 80,000 / microlitre or 50% decrease 
in platelet count from highest value recorded over preceding 3 days 
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5. Unexplained Metabolic Acidosis : A ph < 7.30 or a base deficit           
> 5.0mEq / L and a plasma lactate level > 1.5 times upper limit of 
normal for the reporting laboratory.  
SEPTIC SHOCK:  
        Sepsis with hypotension(Systolic BP < 90 mmHg or 40 mmHg less 
than patienta normal BP) for atleast 1hr despite adequate fluid 
resuscitation or 
Need for vasopressor to maintain systolic blood pressure > 90 
mmHg or MAP > 70 mmHg 
REFRACTORY SEPTIC SHOCK: 
Septic Shock that lasts for >1hr and does not respond to fluid or 
pressor administration 
ETIOLOGY : 
 For the systemic response to occur, the microbes need not enter 
bloodstream, their local invasion itself leads to local inflammation which 
inturn elicits dysfunction of distant organs and drop in blood pressure. 
This can be understood from the fact that blood culture yield organisms in 
only 20-40% and 40-70% of cases of severe sepsis and septic shock 
respectively. 
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Accordingly to one study in 2007, among individuals considered 
infected, 70% showed positive microbiological results. Among them 62% 
showed growth of gram negative organisms and 47% showed growth of 
gram positive organisms and 19% showed growth of candida species 
(fungi)12. Among the gram negative bacteria Pseudomonas species and 
E.coli were most common. Among the gram positive bacteria 
Staphylococcus aureus was most common. 
 Respiratory infection was the most common and was seen in 64% 
of the patients considered infected19. In blood culture negative patients, 
the causative organisms are isolated by microscopic examination or 
culture of infected material from the local site. Microbial RNA or DNA 
in blood or local tissue samples can also be utilized for identification of 
the organism. 
EPIDEMIOLOGY:  
             In United States, severe sepsis contributes to more than 200,000 
deaths in a year. The incidence of severe sepsis and septic shock is more 
than 750,000, affecting nearly 3 per 1000 population. Nearly 2/3rd of the 
cases occur in individuals with significant underlying diseases21. With 
increasing age and preexisting co-morbid conditions the incidence and 
mortality due to sepsis increases. In an international ICU prevalence 
study, the Case Fatality Rate among infected patients was 33% which is 
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significantly high when compared to the uninfected patients, whose Case 
Fatality Rate was only 15%23.In India the incidence of sever sepsis was 
16.45% of all admissions. Hospital mortality and 28-day mortality of 
severe sepsis were 65.2% and 64.6% respectively.53 
PATHOGENESIS: 
Most often Sepsis is kindled by microorganisms, that usually 
doesnot cause systrmic disease in immunocompetent patients. These 
organisms in order to survive with in the human body will exploit the 
acquired deficiencies in host defences, indwelling catheters or other 
foreign matters or obstructed fluid drainage conduits. 
Severe sepsis may be due to different pathogenesis. In severe 
sepsis the pathogenesis varies depending on the  
- Infecting pathogen, 
- The capability of the body’s innate defense system to recognise 
and act to it and 
- The primary tissue infected  
Genetic status, Prior physiologic status and immune status of the 
patient also plays a role. 
In certain patients, as in patients with fulminant meningococcemia, 
the circulating bacteria and their products(endotoxin) itself will directly 
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stimulate inflammatory responses and evokes multiorgan dysfunction and 
hypotension. 
In patients infected with other types of gram negative bacteria the 
uncontrolled infection at a local tissue may be reflected by the presence 
of the bacteria or their products in systemic circulation. They donot attack 
the distant organs directly but the inflammatory molecules released by the 
local tissues triggers inflammation in distant organs leading to severe 
sepsis and septic shock31,36. 
In severe sepsis due to staphylococcus aureus or streptococcus 
pyogenes producing super-antigen a different type of pathogenesis takes 
place, these toxins induce T cell activation which produces a cytokine 
profile different from that evoked by infection due to gram negative 
organisms. 
         The mRNA expression in patients with sepsis is observed to be 
different for gram negative, gram positive and viral organisms. 
LOCAL AND SYSTEMIC RESPONSE OF HOST TO INVADING 
MICROBES: 
Large number of chemical molecules like chemokines, cytokines, 
prostanoids, leukotrienes etc., are produced in large number on 
recognition of the pathogenic organism by tissue macrophages which 
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increases the blood flow to the tissue infected (rubor), increases the local 
blood vessel’s permeability (tumor), recruit cells like neutrophils to the 
site of infection(calor) and produces pain(dolor). These are components 
of local inflammation trying to eliminate the invading microbes. The 
neural and / or humoral communiction with the brainstem and 
hypothalamus activates the systemic responses7, which enhances the local 
response by directing more blood supply to the site of infection, thereby 
recruiting more number of circulating neutrophils and increasing blood 
levels of various molecules like microbial recognition proteins having 
anti-infective action. 
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ORGAN DYSFUNCTION AND SHOCK : 
 When the body mounts response to the foreign organism there will 
be production of various cytokines and molecules, both anti-
inflammatory and pro-inflammatory. As the response increases in 
intensity the presence of these cytokines and molecules in the body also 
increases and in patients with septic shock more than 60 such molecules 
are found to be elevated. 
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 Though both the anti-inflammatory and pro-inflammatory 
molecules are produced in higher concentrations, anti-inflammatory 
molecule takes upper hand in these sick patients. The White blood 
corpuscles, are hyporesponsive in patients with sepsis to LPS like 
agonists6,9.  
This hyporesponsiveness is due to cortisol and/or IL-10. As they 
induce a decreased expression of Class II molecules HLA-DR on the 
surfaces of the circulating leukocytes (Monocytes).  
This decreased expression of the HLA-DR Molecules is one of the 
predictive biomarker, as persistence of the leukocytic hyporesponsiveness 
is associated with increased mortality. Other factors contributing to the 
immunosuppressive state are apoptotic death of CD4+ T lymphocytes, B 
cells and follicular dendritic cells. 
Endothelial Injury: 
 Vascular endothelium plays an important role in regulating 
vascular tone, vascular permeability and coagulation. Leukocyte-derived 
mediators  and platelet-leukocyte-fibrin thrombi leads to injury of 
vascular endothelium. The widely involved vascular endothelial injury all 
over the body is considered as the important mechanism for multiorgan 
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dysfunction. Supporting this concept, a study conducted in septic patients 
showed large number of vascular endothelial cells in the peripheral blood. 
 Vascular endothelial cells produce cytokines, platelet activating 
factor, procoagulants, nitric-oxide and other mediators of inflammation. 
These responses promote the neutrophils  adherence to vascular 
endothelial cells and attracts scavenger cells or phagocytes to the site of 
infection3,5. Not only that, their responses are also associated with 
increased vascular permeability, microvascular thrombosis, disseminated 
intravascular coagulation and hypotension. 
The chemical responses happening in sepsis leads both to 
1) Decrease in the tissue oxygenation and  
2) Decrease in oxygen utilization by the tissue. 
          Decrease in tissue oxygenation is due to decreased blood flow to 
the affected organ which inturn is due to swollen endothelial cells or 
edema fluid and leukocyte-platelet-fibrin thrombi compressing and 
obstructing the capillary lumen. Decrease in oxygen utilization by the 
tissue is due to changes that decreases oxidative phosphorylation and 
ATP production and increases glycolysis in the cells of affected organ. 
Due to increased glycolysis and impaired clearance of the resulting 
lactate and pyruvate by the liver and kidney, there will be increased 
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production of lactic acid leading to its accumulation in the affected 
tissues, thereby reducing the extracellular pH11,13. All these factors and 
cellular changes contributes to the slowing of cellular metabolism in 
those affected tissues. Though these organs affected due to sepsis 
functions poorly they appear  nearly normal at autopsy except for very 
little thrombosis or necrosis. Also these poorly functioning organs return 
back to normal if the patients recover from sepsis. These facts suggests 
that organ hypofunction due to sepsis is mainly due to biochemical 
changes and not structural.  
19 
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Septic shock : 
 Many factors including myocardial depression and hypovolemia 
compromises the oxygen delivery to tissues, the blood lactate 
concentration increases and the central venous oxygen saturation 
decreases during this hypodynamic period. 
The hypodynamic phase is followed by the hyperdynamic 
vasodilatory phase, during this phase the cardiac output will be normal or 
high and the oxygen delivery will be adequate. The blood lactate level 
may be normal or elevated and the central venous oxygen saturation 
improves. Nitric oxide, platelet-activating factor, prostacyclin, bradykinin 
and  - endorphin plays an important role in hypotension related to 
sepsis36. 
CLINICAL FEATURES:    
The clinical features of sepsis vary in different patients. Some may 
present as hyperthermia and some as hypothermia. Sepsis presenting with 
hypothermia occurs mostly in neonates, elderly, uraemia and alcoholic. 
Patients may also present with encephalopathic symptoms like 
confusional state, disorientation etc19. Pre-existing focal neurological 
deficits may become more obvious/ noticeable. Patient may also present 
with hyperventilation leading to respiratory alkalosis. 
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Bacterial toxins may elicit diffuse cutaneous reactions. Various 
cutaneous manifestations include petechiae in Neisseria meningitidis and 
Rocky Mountain Spotted fever, ecthyma gangrenosum by pseudomonas 
aeruginosa in neutropenic patients ,Generalized erythroderma in Toxic 
Shock Syndrome due to Staphylococcus aureus or Streptococcus 
pyogenes etc., Acrocyanosis and Ischemic necrosis of digits and other 
peripheral tissues may occur in patients with hypotension and DIC12,14. 
Gastrointestinal symptoms like nausea, vomiting and loose stools 
occur GI infection. Prolonged or severe hypotension may lead to acute 
hepatic injury resulting in hepatocellular and canalicular dysfunction 
leading to cholestatic jaundice.  
In diabetic patients the blood glucose level mostly increases, but in 
some the defective gluconeogenesis and excessive insulin secretion may 
lead to hypoglycemia. Serum albumin level decreases as a result of 
decreased production by liver, increased protein catabolism and loss into 
interstitial spaces36. The CRP, fibrinogen and complement components 
are increased as a result of acute phase response. 
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COMPLICATIONS :        
CARDIO-PULMONARY : 
Nearly 50% of patients with severe sepsis or septic shock develops 
ARDS or Acute lung injury. In sepsis, there will be increased capillary 
endothelial injury, increased vascular permeability and ther will be also 
excessive alveolar epithelial injury. Both these factors increases the water 
content of lungs, decreasing the pulmonary compliance and hinders the 
oxygen exchange in lungs. The ventilation perfusion mismatch happening 
in the lungs results in decreased arterial pO2.  
         In such a scenario if the pulmonary capillary wedge pressure was 
raised  >18mm of Hg, then heart failure or fluid volume overload status 
has to be considered. Pneumonia due to pneumocystis carinii can also 
present with diffuse infiltrates mimicking ARDS like picture. The 
presence of progressive diffuse lung infiltrates along with decreased 
arterial pO2 (hypoxemia) indicates ARDS provided cardiac failure and 
pneumonia was not present10. 
        ARDS can be classified as mild, moderate and severe depending 
upon the PaO2/FiO2 ratio. 
Mild ARDS (ALI ) : PaO2/FiO2 will be less than or equal to 300 
mm of Hg but more than 200 mm of Hg. 
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Moderate ARDS    :  PaO2/FiO2 will be less than or equal to 200 mm  
    of Hg but more than 100 mm of Hg. 
Severe ARDS       :    PaO2/FiO2 will be less than or equal to 100 mm 
The capillary endothelial damage plays a role in sepsis related 
hypotension. Intially hypotension results due to maldistribution of blood 
flow and blood volume through out the body and from wide spread 
capillary leakage of intravascular fluids leading to hypovolemia. Other 
circumstances that leads to hypovolemia by decreasing the intravascular 
volume in sepsis are dehydration due to preceding disease or due to fluid 
loss from vomiting, diarrhoea or polyuria. Therefore in the intitial stages 
of septic shock cardiac output will be decreased and the peripheral 
vascular resistance will be more. Following administration of fluids the 
cardiac output increases and the peripheral vascular resistance decreases. 
This is the stage which distinguishes septic shock from cardiogenic and 
hypovolemic shock21. Normal or increased cardiac output with fall in 
systemic vascular resistance apart from septic shock can be also seen in 
Anaphylaxis, liver cirrhosis, Beriberi and Nitroprusside or Narcotic 
overdoses.  
Hypotension may also result from depressed myocardial function. 
Most of the patients with septic shock presents with decreased ejection  
fraction and increased end diastolic and systolic ventricular volumes due 
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to depressed myocardial function, however due to ventricular dilatation 
the cardiac output will be maintained. Though depression of myocardial 
function leads to hypotension, refractory hypotension results invariably 
due to decrease in systemic vascular resistance. 
ADRENAL GLANDS: 
In critically ill patients hypotension refractory to fluid therapy may 
occur due to adrenal insufficiency. This can be defined by the term 
CIRCI – Critical Illness Related Corticosteroid Insufficiency. 
This can be due to the following mechanisms . 
1) Reversible hypothalamic pituitary axis dysfunction 
2) Glucocorticoid receptor abnormalities resulting in tissue 
corticosteroid resistance  
3) Increased conversion of serum cortisol to cortisone 
Patient with CIRCI doesnot respond to fluid therapy and needs 
inotropic / vasopressor support. When the plasma cortisol  level falls 
below 15 microgram/ml adrenal insufficiency is considered49. 
KIDNEYS: 
Hypovolemia, arterial hypotension or toxic drugs leads to acute 
tubular necrosis which in turn leads to renal failure. Some patients may 
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also develop glomerulonephritis, interstitial nephritis or renal cortical 
necrosis. This patients may present with oliguria or polyuria, uremia, 
proteinuria and urinary casts. 
COAGULATION: 
 Thrombocytopenia occurs in 10-30% of septic patients but the 
underlying mechanism is not known. In DIC the platelet count decreases 
as low as less than 50,000 mainly due to endothelial damage and 
microvascular thrombi formation utilizing the platelets. 
NERVOUS SYSTEM: 
10-70% of the sepsis patients develops delirium during their course 
in hospital and is one of the earliest manifestation of sepsis. Patients with 
septic illness for a longer period of weeks or months may develop a entity 
called critical illness polyneuropathy with distal motor weakness which 
can be diagnosed with electrophysiological studies. Studies have showed 
long term cognitive impairment in survivors of severe sepsis. 
IMMUNOSUPPRESSION: 
Most of the patients with severe sepsis become immunosuppressed. 
It usually presents as inability to control the primary infection, liability to 
secondary infection like candida albicans and loss of type 4 (delayed) 
hypersensitivity reaction to common antigens42. This is evidenced by the 
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reactivation of herpes simplex virus, herpes zoster virus or 
cytomegolovirus infection in nearly 1/3 rd of the patients.  
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LABORATORY FINDINGS: 
Blood investigation shows leukocytosis with shift to left or 
leukopenia. Neutrophils with toxic granulations, dohle bodies or 
cytoplasmic vacuoles are seen in peripheral smear26,28. Platelet count 
decreases, thrombocytopenia worsens with the severity of septic 
response. Presence of D-dimers with prolonged thrombin time and 
decreased fibrinogen and microangiopathic changes in peripheral smear 
suggests DIC. 
Uremia, hyperbilirubinaemia, raised serum aminotransferases and 
hypoalbuminemia and proteinuria may be present. Uncontrolled 
hyperglycemia with DKA develops in most of the diabetic patients. DKA 
leading to dehydration and volume loss may precipitate hypotension. 
Rarely hypoglycemia develops as a result of adrenal insufficiency. 
ABG reveals respiratory alkalosis due to hyperventilation in early 
sepsis. With accumulation of blood lactate and as the respiratory muscles 
fatigues high anion gap metabolic acidosis ensues. ABG also may show 
hypoxemia, initially responding to oxygen therapy later becoming 
refractory to 100% oxygen. Chest X-ray may be normal or may show 
pneumonic consolidation, pulmonary edema or diffuse infiltrates of 
ARDS. Sinus tachycardia or nonspecific ST-T wave changes may be seen 
in ECG. 
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Sepsis can be diagnosed from the clinical presentation like fever or 
low body temperature, hyperventilation (tachypnoea), tachycardia and 
altered mental status. Blood investigations showing leukocytosis or 
leukopenia, thrombocytopenia, elevated blood lactate level or repiratory 
alkalosis can also aid in diagnosis. The systemic response to infection 
varies in each individual. Also the systemic responses due to non 
infectious etiology may also be similar to that of sepsis complicating the 
diagnosis. 
A study had shown that in patient with severe sepsis 36% had a 
normal body temperature, 40% had normal respiratory rate, 10% had 
normal pulse rate and 33% had normal TLC34. In such cases gram 
staining aids in diagnosis. 
To identify the exact organism causing infection it has to be 
isolated from blood or other sites of infection. In most of the cases blood 
culture will be negative due to antibiotic administration before drawing 
blood sample for culture or when the causative organism is a slow 
growing or fastidious organism or the microorganism wouldn’t have 
entered the blood stream. In such cases gram staining and culture of the 
substances taken from the site of primary infection aids in pointing the 
causative organism. The nuclear material(DNA or RNA) of the 
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microorganism can be isolated / extracted from the blood or infected 
tissues by Polymerase chain Reaction. 
TREATMENT: 
Antimicrobials: 
Patient with sepsis should be evaluated and dignosed rapidly so 
that early and vigorous treatment can be given. Treatment should aim in 
clearing the infection and the source of infection with antibiotics and by 
excising or draining the infected material. Patient’s hydration, 
hemodynamic status and respiration should be taken care of. Appropriate 
empirical antimicrobial covering both gram positive and gram negative 
organisms based on the local microbial susceptibilities should be started 
soon after blood and other infected samples are collected for culture. 
Retrospective studies had shown that a delay of even one hour between 
the onset of hypotension and initiation of appropriate antimicrobial agents 
had resulted in poor survival rate / outcome16 . Once the culture reports 
are obtained antibiotic can be changed according to the organism and its 
susceptibility. Most of the gram negative organisms require single 
antimicrobial other than pseudomonal infection in which a combination 
of aminoglycoside with an antipseudomonal beta lactum antibiotics are 
required. 
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Empirical antifungal has to be considered in  
- Patients with neutropenia for more than 5 days ,  
- Patients who are hospitalized in ICU for a longer period, 
- Patients with an indwelling central venous catheter for a long  
period  
- Patients receiving parenteral nutrition or if the 
- Patient is already receiving broad spectrum antibiotics. 
The antimicrobial regimen has to be reconsidered daily based on 
patient response. Culture negativity should never be considered an 
indication for discontinuing antimicrobials5,8. 
Removing the source of infection: 
The source of infection has to be removed like draining the pus and 
excision of the infected tissue and removal of indwelling  catheters. Foley 
and drainage catheters should be changed periodically. 
Hemodynamic, Respiratory and Metabolic support: 
Hypotension has to be managed by adequate infusion of fluids, 
while monitoring central venous pressure to prevent pulmonary edema. 
About 1/3rd of the patients respond to fluid therapy. MAP of more than 
65mm of Hg (SBP more than 90 mm of Hg) has to be maintained22. If 
this could not be achieved with volume repletion alone, the vasopressors 
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has to be administered, norepinephrine can be infused via central venous 
catheter. Incase of myocardial dysfunction, inotropic agent dobutamine is 
preferred. In patients not responding to fluids, CIRCI has to be suspected 
and hydrocortisone has to be given and continued if clinical improvement 
happens. Mechanical ventilation has to be considered for patients in 
respiratory distress, Respiratory Rate more than 30 breaths per min, 
hypoxemia and hypercapnia. Hyperglycemia has to be controlled. 
Dialysis can be considered in patients with acute renal failure. 
PROGNOSIS: 
Nearly 40-60% of patients with septic shock and 20-35% of 
patients with severe sepsis die within 30 days rest die with in the next 6 
months46. In both culture positive and culture negative cases case fatality 
rates are similar. After the 4th decade of life CFR gradually increases to 
more than 35% in the elderly population indicating the role played by age 
in prognosis. Another strong predictor of mortality is septic shock. 
Scoring systems such as APACHE II helps in estimating the mortality 
risk. 
PREVENTION: 
In developed countries most cases of severe sepsis and septic shock 
occurs due to nosocomial infection. These can be prevented by avoiding 
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unwanted catheterization, IV lines, feeding tubes etc and by decreasing 
the duration of use. Unnecessary use of antibiotics and glucorticoids 
should be avoided. Localized infection has to be aggressively treated and 
controlled before the stage of severe sepsis or septic shock. Studies have 
shown that nearly 50-70% of patients who develops severe sepsis or 
septic shock due to nosocomial infection would have gone through a 
stage of less severe systemic response to sepsis on atleast one previous 
day. Therefore, further research is essential to recognise patients at high 
risk. 
SEPSIS IN ELDERLY: 
Sepsis and ARDS are more common in elderly and are the most 
common cause of ICU admission. The mortality from sepsis increases 
with age. The most common reason for older patients getting admitted to 
hospital is sepsis and is nearly fourfold more than the admission rate for 
acute coronary events. Pneumonia one of the major cause of mortality is 
the most common cause of infectious death and also the leading cause of 
severe sepsis and septic shock50. With increasing age the incidence of 
pneumonia increases and is related with increased morbidity, mortality 
and health care costs. In older adults the most frequently acquired 
bacterial infection is UTI and is one of the commonly diagnosed infection 
in elderly. 
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Bacteremia and Sepsis: 
 The bacteremia rates in older adults are very higher when 
compared with their younger counter parts. In geriatric units upto 14% of 
all admissions are due to bacteremia. Systemic signs like fever, chills and 
diaphoresis are less common in older patients than young patients with 
bacteremia. In older adults the causative agents is mostly a gram negative 
rod as bacteremia is more likely to result from a gastrointestinal or 
genitourinary infection than in young adults. The prognosis of sepsis in 
older individuals in worse, reduced physiologic reserve due to aging and 
comorbidities that deteriorate their ability to recover from septic event is 
a major contributing factor to this worst prognosis. 
The 28day mortality rate for sepsis is 26% to 33% in young adults 
and 35% to 42% in older adults with age more than 65 years. Mortality 
rate due to nosocomial gram negative bacteremia is 5% to 35% in young 
adults and 37% to 50% in older adults12,15,18. Mortality is reduced if an 
appropriate antibiotic which covers the eventually isolated organism is 
included in the starting regimen. 
The increase in organ failure in patients with infection is the reason 
behind the increase in the number of admission for sepsis. In critical 
illness like sepsis the physiological reserves and the capacity to maintain 
homeostasis will be diminished resulting from chronic illness related 
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lifetime random molecular damage, injuries, environmental and 
epigenetic factors acting along with the proinflammatory state of aging, 
provoking organ failure necessitating intensive care. 
Aging related physiological changes relevant to critical ill patients: 
Respiratory Failure: 
Respiratory failures necessitating mechanical ventilation is the 
most common reason for ICU admission. The increased respiratory 
demands will not be compensated due to age related chest wall, 
parenchymal and vascular changes. 
Chest wall:  
In advanced age patient develops kyphosis and osteoporosis 
narrowing the intercostal spaces, ribcage calcification and sarcopenic 
changes affecting intercostal muscles and diaphragm reducing the chest 
wall efficiency. 
Lung Parenchyma:  
With ageing, alveolar surface area decreases and the lung 
surfactant composition changes. This decreases the parenchymal 
elasticity and therefore decreasing the vital capacity and FEV1 (forced 
expiratory volume in 1 second). These parenchymal changes leads to 
premature closure of smaller airways, especially in the lower zones where 
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the blood supply is more, resulting in ventilation perfusion V/Q 
mismatching. The oxygen uptake by the blood is decreased as a result of 
decreased alveolar surface and V/Q mismatch. 
Cardiovascular failure :  
With ageing both the systolic and diastolic cardiac function 
declines, the stroke volume and ventricular filling also will be reduced. 
The capability to increase the stroke volume during an event of acute 
stress will be decreased in older adults as ventricular hypertrophy results 
in increased ventricular size but there will be decrease in the cardiac 
myocytes and functional myocardium. The ventricles will be 
hypertrophied and stiff, depending on the atrial contractions for 
ventricular filling. There will be decrease in the response to beta-
adrenergic stimuli with ageing, decreasing the heart rate and the heart rate 
response to variations in blood pressure. Thus in the event of shock the 
heart of aged persons tries to maintain the cardiac output by mechanisms 
that increases preload like by increasing the stroke volume and 
ventricular filling than by increasing the rate of contraction. In the setting 
of stiff ventricles aggressive fluid therapy results in pulmonary edema, so 
care should be taken while repleting volume. 
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Renal failure: 
 Critically ill older patients are at increased risk of developing acute 
renal failure. The GFR decrease approximately by 1.0 ml/min/1.73m2 /yr 
beginning from the 3rd decade of life48. The GFR decreases as a result of 
decrease in the renal blood supply, structural changes affecting both 
afferent and efferent arterioles hindering autoregulation during decrease 
or increase in blood pressure and due to loss of glomeruli and renal 
tubules. The ability to concentrate urine and maintaining electrolyte 
balance / homeostasis decreases with ageing resulting in potential volume 
status and electrolyte problems.The renin-angiotensin-aldosterone system 
mediated vasoconstrictor response to hypovolemia, shock or medication 
is augmented by age related decrease in prostaglandin synthesis. Though 
the GFR decreases, there will not be co-existing increased serum 
creatinine as a result of decreased creatinine production due to muscle 
loss leading to decrease in muscle mass (sarcopenia). With advanced 
ageing sarcopenia increases. The number of muscle fibres will be reduced 
with higher intramuscular lipid concentrations and motor unit remodeling 
in sarcopenic skeletal muscles leading to decreased muscle power and 
strength, easy fatiguability and slow gait speed. Critical illness especially 
with the background of multiple organ failure, like in sepsis leads to 
additional muscle breakdown by altering atrophy – hypertrophy 
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signalling pathway. Immobility during critical illness play a part in 
muscle loss, decreased aerobic capacity and decrease in strength. 
With ageing there will be decline in cognitive function mainly in 
working memory, short term memory and processing speed. The 
immunological and hormonal feedback mechanisms exhausts and impel 
unusual stress responses during events of acute stress like sepsis resulting 
in neuroinflammation and neurodegeneration. In susceptible patients the 
cycle of neuroinflammation and degeneration may lead to 
neurotransmitter imbalances, metabolic abnormalities and oxidative stress 
disrupting neuronal networks manifesting as acute confusion or delirium. 
A vicious cycle of neuroinflammation and neurodegeneration following 
an acute stress results in significant neuronal loss and cognitive decline. 
Nutritional Imbalance: 
Under feeding and delay in nutritional support, both of which 
common during intensive care may be detrimental, older critically ill 
patients are at high risk of malnutrition compared with their fellow young 
people. Since these patients will not be able to maintain adequate oral 
intake due to their illness enteral or parenteral nutrition should be 
provided. 
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FACTORS PREDISPOSING TO INFECTION IN ELDERLY: 
 Several risk factors like comorbidities, malnutrition, immune 
senescence and social factors affecting health (ex: poor access to health 
care, nursing home residents) increases the risk of infection in elderly 
when compared to young individuals. 
Comorbidities: 
 In elderly patients, there is increase in occurrence of infection and 
mortality from infectious diseases likely resulting directly from the 
comorbid conditions like diabetes, renal failure, pulmonary disease, 
immobility and edema  associated with increased age43. Comorbid 
conditions mostly results in diminished innate immunity. Non – specific 
barriers like skin integrity, cough reflex, mucociliary clearance and 
immune responses activated by recognition of sequence of microbial 
products like endotoxin, lipoteichoic acid etc., without the necessity of 
previous exposure( complements, tissue phagocytes like PMN’s and 
TLR’s) are critical innate immune components. Innate immunity produce 
responses non specific to an organism or antigen, for ex: the diminished 
mucociliary clearance, dysfunction of alveolar macrophages and impaired 
cough mechanism considerably heightens the risk for lower respiratory 
tract infection in elderly patients with COPD. 
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Waning Immunity: 
Immune senescence in not only a complete state of decreased 
immunity but also a impairment of immune responses at multiple levels. 
Defect in adaptive T-cell responses is the most constant immune deficit 
seen with increasing age. The naive T-cell subsets will be decreased37, 
cytokine production especially IL-2 and cellular surface receptors, IL-2 
receptors and CD-28 will be severely suppressed. There will be 
suppression of T-cell responses by inhibition of T-cell immunity such as 
IL-10 and PGE2 by inflammatory cytokines.  
Immuno senescence: 
 Changes in the immune system occurring with ageing is referred as 
immuno senescence. It affects all cell lineages of the immune system 
extending to hematopoietic stem cells in the bone marrow. This leads to 
modification in the diverse innate immune responses encountering the 
pathogens earlier as well as the highly specific and slower onset adaptive 
immune responses in B & T cells. It also affects molecular pathway in all 
the levels of immune response. All these ends up in low level 
inflammation at baseline, with impaired innate and adaptive immune 
response to an acute stimulus37. Responses to naive antigens are more 
often impaired than memory responses. Impaired differentiation and 
repopulation of blood cell lineages are seen with aging. 
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Heightened Proinflammatory Environment in Elderly: 
Inflammaging is a phenomenon of increased levels of 
proinflammatory  cytokines like IL – 6 and TNF α. Acute phase reactants 
like CRP and clotting factors are seen in the older adult’s plasma when 
compared to the younger adults.  
Adaptive Immunity: 
Adaptive immunity is a highly specific immune responses brought 
about by lymphocyte specific antigen receptors. In B-cells the 
immunoglobulins or antibodies control the humoral immunity. The 
immunoglobulins are both secreted and membrane bound as the B-cell 
antigen receptor. In T-cells, the T-cell receptor which is membrane 
associated only, mediates the cell mediated immunity. Humoral and cell 
mediated immunity shows immunologic memory, responsible for 
enhanced response both in speed and antigen recognition affinity to 
previously encountered antigens upon repeat exposures14.  
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Nutritional Factor: 
 In older patients above 65 years of age admitted to the hospital, 
PEM is present in 30% to 60% of them. It is associated with retarded 
wound healing, development of pressure sores, CAP, high risk of hospital 
acquired infection, prolonged hospital stay and increased mortality. 
Adequate nutrition is required for good wound healing and functional 
recovery from severe infectious diseases. PEM is associated with poor 
vaccine response25. Micronutrient deficiencies are also associated with 
risk of infection and poor immune function and are common in elderly 
population. 
Social and Environmental Factors: 
 Health of elders is also a function of socio – economic status, 
environment and availability of health care services and not only that of 
biomedical variables. Poor nutrition, increased exposure to micro 
organisms causing infection (ex:grandparents taking care of  small 
children) increased chances of comorbid diseases due to pollution / 
tobacco exposure or difficult health care access may predispose to 
infection among lower socio-economic status. The close contact between 
residents plays an important role in the dissemination of respiratory 
infections in long-term care residents. The close proximity of residents, 
improper adherence to basic infection control measures and the intense 
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use of antibiotic are factors leading to the spread of antibiotic resistance 
bacteria such as MRSA, VRE etc.,19,21  
DIAGNOSIS AND MANAGEMENT OF INFECTION IN 
ELDERLY PATIENTS: 
 Infectious diseases mostly present with atypical symptoms in 
elderly. Serious life threatening infections may present with non –specific 
features like decline in patients function or mentation or decreased food 
in take. Underlying comorbid conditions like CHF / Diabetes may be 
exacerbated by infection making patient to seek medical attention for the 
symptoms associated with comorbidity. Fever, considered the common 
symptoms of infection will be mostly absent in the elderly. Studies have 
shown that the mean baseline temperature will be lower in frail older 
adults and not the currently accepted normal of 37O C (98.6 OF). 
 In animal models of ageing, with advanced age the rise in body 
temperature in response to cytokines (IL-1, IL-6, TNF –α) that rise body 
temperature are diminished. The lowering of basal temperature and 
decreased response to inflammatory cytokines makes the achievement of 
a body temperature commonly recognised as fever very less likely46. The 
diminished febrile response mostly leads to delay in diagnosis and 
indicates bad prognosis.  
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It has been suggested that fever in older adults has to be defined as, 
1. Constant rise of body temperature of atleast 1.1O C (2 OF) over 
baseline temperature (or) 
2. Oral temperature of 37.2OC (99 OF) or more on repeated 
measuring (or) 
3. Rectal temperature of 37.5OC (99.5 OF) or more on repeated 
measuring. 
Cognitive impairment also makes the diagnosis of infection 
difficult in older patients as it is difficult to interact with them and to ask 
for their symptoms. 
Antibiotic Management and Stewardship: 
The physiologic changes happening with ageing and comorbidities 
affects distribution of drug, drug metabolism, drug interactions and 
excretions. In view of the changes in renal function the predispositions to 
side effect in older adults often leads to the motto of start low and go 
slow among physicians while treating the elderly. This is not an 
appropriate idea while administering antibiotics.  
Various factors including gastric motility, poor absorption, 
increased adipose tissue and administration of other drugs along with 
antibiotics decreases the blood level of antibiotics. As the antibiotics 
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reach the tissues through blood flow, decreased blood flow to the affected 
tissues may reduce the efficacy of the antibiotics. Therefore antibiotics 
are required at higher levels especially for efficacy in elderly people 
where the earliest reaching of adequate levels of antibiotics is necessary 
than in younger adults as the outcome of serious infection is dependent on 
that. It is very important to give antibiotic coverage for MRSA, resistant 
gram negative rods, enterococci and other resistant organisms when the 
clinical suspicion for resistant organism in an older individual is high37, 
The nursing home residents in particular constitute a high risk population. 
PROCALCITONIN: 
Procalcitonin, the 116 aminoacids long precursors of the hormone 
calcitonin is synthesised normally by C-cells of thyroid. In normal 
physiological conditions the serum procalcitonin level will be as low as 
less than 0.05 ng/ml but in cases of bacterial infection its blood level will 
be raised as a result of synthesis from extra-thyroidal parenchymal cells 
especially neuro endocrine tissues. Procalcitonin production will be 
stimulated by both bacterial endotoxin or lipopolysaccharide and 
cytokines. The systemic rise in procalcitonin is highly specific to 
bacterial infections and is a component of the systemic response53. 
Procalcitonin apart from rising rapidly also undergoes rapid cleavage 
when infection is controlled by immune system with effective antibiotic 
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treatment. In viral infection procalcitonin will be down regulated. The 
serum procalcitonin will be highest in bacterial infection with minimal 
rise in cases of viral infection and in localised and intracellular bacterial 
infections. 
 The procalcitonin level is also significantly raised in gram negative 
bacteremia when compared to gram positive infections. Following the 
onset of systemic response the procalcitonin level starts rising at 4 hrs, its 
blood level peaks between 8 and 24 Hrs., which is earlier when compared 
to the most commonly used biomarker CRP which slowly rises, peaks 
after 36 hrs of systemic response22,24.  
Procalcitonin is referred to a hormokine mediator due to its dual 
function as a precursor molecule from calcitonin, a hormone  and as a 
cytokine mediator which is elevated along with other cytokines upon 
systemic bacterial infection. Unlike other biomarkers (ex: CRP) the 
procalcitonin production seems to be not diminished by non-steroidal  
and steroidal anti-inflammatory drugs. An experiment in rats showed that 
procalcitonin peak values was higher significantly in rats stimulated with 
a component of the outer membrane of gram negative bacteria, 
lipopolysaccharide when compared with rats stimulated with a 
component of the outer membrane of gram positive bacteria, muramyl 
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dipeptide showing that the procalcitonin level rise in relation to the type 
of pathogenic microbes52. 
Procalcitonin level will be raised in patients with renal impairment, 
post-surgical or trauma and in pancreatitis. The half life of procalcitonin 
is 24 hrs, therefore it can be transported to laboratory for analysis along 
with other tests. The serum level of procalcitonin will be higher in 
patients with CKD when compared to normal subjects and its level is 
found to decrease with hemodialysis.  
Procalcitonin as a diagnostic marker of Sepsis: 
 A number of studies were being done evaluating the diagnostic 
potential of procalcitonin in critically ill patients. The results are 
conflicting making it difficult to arrive at a conclusion. Two metaanalyses 
results were as follows. The first one by Uzzan et al, reviewed and 
analysed 25 studies to compare the diagnostic potential of procalcitonin 
against CRP. The results were as  follows. The sensivities of 
procalcitonin ranged from 42% - 100% where as for CRP it ranged from 
35% - 100%. The specificities ranged from 48% - 100% for procalcitonin 
and 18% - 84% for CRP. According to their metaanalysis the 
procalcitonin had a global diagnostic accuracy and of ratio 15.7 where as 
for CRP it is 5.4.Measures of performance, Q value least affected by the 
study heterogeneity was 0.78 for procalcitonin and 0.71 for CRP. 
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Procalcitonin had a significantly higher Q value when compared to CRP 
P=0.0251,52. 
The second study by Tang et al reviewed and analysed 18 studies. 
According to their study both specificity and sensitivity had a mean 
values of 71%. The Q value for procalcitonin was 0.72. Uzzan et al came 
to a conclusion that procalcitonin constitute a good biomarker in the 
diagnosis of sepsis and has to be included in the diagnostic guidelines for 
sepsis and in clinical practice in critical care. Where as Tang et al 
concluded that the procalcitonin has a poor diagnostic performance and 
that it can’t reliably differentiate sepsis from other non infectious causes 
of SIRS53. 
Ruiz-Alvarez et al in his study in 103 intensive care patients with 
suspected sepsis found that procalcitonin and SOFA score to be the only 
independent predictors of infection and not CRP. Rau et al also concluded 
in his study that procalcitonin is better than CRP in diagnosing infection 
and MODS. Based on these studies procalcitonin proves to be a better 
diagnostic marker of sepsis when compared to CRP.  
Procalcitonin in dignosing health care associated infection in ICU: 
In  critically ill patients who deteriorate due to intercurrent 
infections like in VAP, procalcitonin can be used to dignose infection. It 
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is difficult to dignose patients suspected to have VAP, as the patients may 
show non specific signs and  symptoms with no gold standard diagnostic 
test.  Even the microbiological cultures is not of much significant due to 
microbial colonization of the upper respiratory tract. In such situation 
serial procalcitonin testing aids in the diagnosis of infection following 
hospitalization48,49. Studies in which procalcitonin was measured on Day 
0 of suspected infection and 2-3 days prior to that showed significant rise 
and procalcitonin on Day 0 in patients with infection when compared 
with patients with out infection. Concluding that a rise in serum 
procalcitonin from base line following admission in critically ill patients 
should suspect infection and there by helps in reducing unwanted 
antibiotic exposure and there by antibiotic resistance45,46. 
Procalcitonin as a prognostic marker in Sepsis: 
With increasing severity of sepsis and dysfunctioning organs, 
serum procalcitonin levels tends to rise. A study by Jensen et al, a 90 days 
study in 472 critical care patients performed daily procalcitonin 
determination and compared the results with all cause mortality. They 
concluded that an increase in  procalcitonin following a reading of more 
than 1.0 ng / ml and a high maximum procalcitonin were both predictors 
of mortality independently .With everyday rise of procalcitonin following 
a value of more than 1.0 ng/ml the relative risk for mortality continued to 
51 
 
increased. Where as CRP and WBC was not significant in predicting 
mortality. In one study there was a significant differences between 
survivors and non survivors in procalcitonin  values on Day 1 & 2 
following admission in critical care unit . There was statistically 
significant differences for IL-6, APACHE and SOFA scores also53. 
Though APACHE and SOFA scores are validated for stratifying 
mortality risk, they are clinically unwieldy and are not used much for 
clinical decision making. Hence a quickly available biomarker that gives 
prognostic information similar to that of APACHE II and SOFA will be 
of more used, for example for early interventions and to discuss about 
patients prognosis with their relatives. A rising procalcitonin level can be 
used as an indicator of poor or uncontrolled infections and there by 
measures for  better control of the source can be taken. 
Procalcitonin in Antibiotic Stewardship: 
With daily monitoring of serum procalcitonin, the antibiotics can 
be safely stopped once the procalcitonin level comes down or reduces to a 
certain percentage. The PRORATA trial, a randomized trial in 8 french 
ICU, compared antibiotic therapy based on procalcitonin with usual care 
mainly for non surgical patients with suspicion of bacterial sepsis. On 
admission antibiotics were prescribed for same proportion of patients in 
both the cohorts.  
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Procalcitonin monitored patients had an overall increased number 
of days without antibiotic exposure than control patients and they had a 
significantly fewer days of antibiotics exposure. Procalcitonin has to be 
used in adjunct with clinical evidence of sepsis32.  
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METHODOLOGY 
Methodology (Materials and Methods) 
 
Study Centre       :    Geriatric Medicine Wards, G.I.C.U                  
Rajiv Gandhi Government General Hospital,  
Chennai-3. 
 
Study Duration      : 6 months (March 2017 to August 2017) 
 
Ethical Committee  :    Clearance otained 
 
Study Design      :    Cross sectional and observational study 
 
Sample size       :    75 patients 
 
Inclusion criteria    :      
Patients above 60 years of age with a diagnosis of Sepsis and 
willing  to consent for the study       
 
Exclusion criteria   :       
 Patients above 60 yrs of age not willing to consent for the study  
 Patients who underwent surgery or trauma during the previous 
72 hrs 
 Patients with burns and acute pancreatitis                                          
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Procedure: 
            Patients admitted in Geriatric Wards and G.I.C.U, fulfilling the 
inclusion criteria are enrolled. History including demographic 
charecteristics(age and sex), co-morbidities and physical examination 
findings are recorded. Blood sample were drawn from patients within 24 
hrs following admission for basic laboratory investigations including 
basic biochemistry, complete blood count, coagulation profile and other 
relevant investigations for sepsis inluding CRP and Procalcitonin, 
Microbiological cultures from the suspected sources of infection were 
also done on admission. Scoring for severity of illness like APACHE II 
and SOFA scoring were done on admission. The role of Procalcitonin in 
the diagnosis and prognosis of sepsis in elderly is assessed and compared 
with the other standard markers of sepsis based on mortality of the 
patients. 
Measurement of Procalcitonin: 
Using a sterile syringe, 5ml of venous blood was drawn after sterile 
precautions on admission, The sample should be kept at room 
temperature for 2hrs and should be centrifuged for 10 min at 3000rpm. 
Until analysis, the supernatant has to be stored at -70 degree celsius. 
Serum Procalcitonin was measured using chemiluminiscence 
technique.the test has to be done on a fully auto chemiluminiscence 
immune assay analyser. 
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Biological Reference Interval: 
<0.5            :     Normal subjects, chronic inflammatory processes,  
   viral  infection and mild to moderate localized  
   bacterial infection 
<0.5 – 2.0   :     SIRS, multiple myeloma, burns 
>2.0             :     Severe bacterial infections, sepsis, multiple organ  
   failure 
 
APACHE II  Scoring System: 
 
APACHE II is a mortality predictor score commonly used to assess 
the baseline risk groups being compared in clinical trials. APACHE 
scoring will not help in the management of patients, but it is a useful tool 
for risk stratification.  
The APACHE II score provides an estimate of ICU mortality based 
on a number of laboratory values and patient signs taking both acute and 
chronic disease into account. 
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APACHE II SCORE Approximated Mortality Rate 
0 - 4 4% 
5 - 9 8% 
10 - 14 15% 
15 - 19 25% 
20 - 24 40% 
25 - 29 55% 
30 - 34 75% 
>34 85% 
 
SOFA Score: 
          The SOFA (Sequential Organ Failure Assessment) score is a 
mortality prediction score that is based on the degree of dysfunction of 6 
organ systems. It is a scoring system that assess the performance of 
several organ systems in the body(neuriologic,blood,liver,kidney and 
Blood Pressure / Hemodynamics) and assigns a score based on the data 
obtained in each category. The higher the score ,the  higher the likely 
mortality. SOFA score has been recommended for assessment of patients 
with sepsis by the new 2016 Sepsis Definitions Consensus Statement. 
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MAXIMUM  SOFA  SCORE MORTALITY 
0 to 6 < 10% 
7 to 9 15 – 20% 
10 to 12 40 – 50% 
13 to 14 50 – 60% 
15 >80% 
15 to 24 >90% 
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Data collection and Methods: 
             Collection of data as per proforma with consent from patients or 
their bystanders enrolled in the study. 
 
Data Analysis: 
              Using appropriate statistical methods, the significance of 
Procalcitonin as a marker in Elderly patients with sepsis is studied 
 
Sponsorship                    :       None 
Conflict of interest        :       None 
Consent                      :      Informed consent from all patients or their  
            bystanders enrolled in the study 
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OBSERVATION AND RESULTS 
An observational study was carried out in 75 elderly patients aged 
60 and above of both the sex who fulfilled the criteria for Sepsis. The 
study was conducted for a period of 6 months.The characteristics of the 
sample population is as follows. 
SEX  DISTRIBUTION 
SEX Frequency Percent 
Male 42 56.0 
Female 33 44.0 
Total 75 100.0 
 
 
 
 
In our study the percentage of male patients above 60 yrs with 
sepsis was 56% and the percentage of female patients was 44%. This 
shows that the proportion of male patients above 60yrs of age with sepsis 
is higher than that of females at that point of time. 
44%
SEX
Male
Female
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Crosstab 
 Mortality Total 
Died Survived 
Sex 
Male 
Count 21 21 42 
% within Death 53.8% 58.3% 56.0% 
Female 
Count 18 15 33 
% within Death 46.2% 41.7% 44.0% 
Total 
Count 39 36 75 
% within Death 100.0% 100.0% 100.0% 
Pearson Chi-Square=0.153 p=0.696 
 
Crosstab 
 
Sepsis Type 
Total 
septic shock severe sepsis 
Sex 
Male 
Count 21 21 42 
% within Sepsis 
type 
53.8% 58.3% 56.0% 
Female 
Count 18 15 33 
% within Sepsis 
type 
46.2% 41.7% 44.0% 
Total 
Count 39 36 75 
% within Sepsis 
type 
100.0% 100.0% 100.0% 
Pearson Chi-Square=0.153 p=0.696 
      
Among the 42 males in our study, 21 had severe sepsis and 21 had 
septic shock with a mortality of 21(58.3%) 
Among the 33 females in our study,15 had severe sepsis and 18 
had septic shock with a mortality of 15(41.7%) 
In our study there is no statistical significance in the severity of 
sepsis or mortality based on sex  
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AGE DISTRIBUTION 
 
AGE Frequency Percent 
60-69 years 38 50.7 
70-79 years 20 26.7 
80+ years 17 22.6 
Total 75 100.0 
 
 
 
 
 
 
In our study age group ranges from 60 to 101 yrs.  
The mean age group was 73 years. 
The maximum number of  patients were in the age group of 60 to 69. 
 
  
51%
27
22%
Age group
60-69 years
70-79 years
80+ years
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Death 
Total 
SURVIVOR 
NON 
SURVIVOR 
Age 
group 
60-69 
years 
Count 27 11 38 
% 71.05% 28.95% 100.00% 
70-79 
years 
Count 6 14 20 
% 30.00% 70.00% 100.00% 
80+ 
years 
Count 6 11 17 
% 35.29% 64.71% 100.0% 
Total 
Count 39 36 75 
% 52.00% 48.00% 100.00% 
Pearson Chi-Square=11.306*  p=0.004 
 
 
 
 
In our study mortality increased with increasing age  
There is a significant co-relation between increasing age and mortality.  
Maximum mortality is seen in patients  above 70yrs of age 
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Death 
Total Septic 
shock 
Severe 
sepsis 
Age 
group 
60-69 
years 
Count 23 15 38 
% 60.53% 39.47% 100.00% 
70-79 
years 
Count 11 9 20 
% 55.00% 45.00% 100.00% 
80+ 
years 
Count 5 12 17 
% 29.41% 70.59% 100.00% 
Total 
Count 39 36 75 
% 52.00% 48.00% 100.00% 
Pearson Chi-Square=4.034* p=0.045 
 
 
 
       Among the 75 patients in our study, 38(50.7%) of them were in the 
age group of 60-69yrs, 15 of them with severe sepsis and 23 with septic 
shock accounting together for a mortality of 30.6 %. Between 70-79 years 
of age, there were 20(26.7%) subjects, among them 9 were with severe 
sepsis and 11 with septic shock accounting together for a mortality of 
38.9%. Between 70-79 years of age, there were 17(22.7%) subjects, 
among them 12 were with severe sepsis and 5 with septic shock 
accounting together for a mortality of 30.6% 
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SEVERITY OF SEPSIS 
 
Severity of Sepsis Frequency Percent 
Septic shock 39 52.0 
Severe sepsis 36 48.0 
Total 75 100.0 
 
 
 
 
 
 
 
 
Out of the 75 subjects in our study, 36(48%) of them presented 
with severe sepsis and 39(52%) with septic shock 
  
52%
48%
Severity of Sepsis
Sepsis shock
Severe sepsis
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OUTCOME 
Death Frequency Percent 
Survivor 39 52.0 
Non Survivor 36 48.0 
Total 75 100.0 
 
 
 
 
 
 
In our study the overall mortality due to sepsis was 48%  
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ACUTE  RENAL FAILURE 
 
ARF Frequency Percent 
Absent 30 40.0 
Present 45 60.0 
Total 75 100.0 
 
 
 
 
 
 
In our study of 75 patients, 45 presented with acute renal failure 
accounting for 60 percent of the study population  
40%
60%
ARF
Absent
Present
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Crosstab 
 
Death 
Total 
no yes 
ARF 
absent 
Count 21 9 30 
% within Death 53.8% 25.0% 40.0% 
present 
Count 18 27 45 
% within Death 46.2% 75.0% 60.0% 
Total 
Count 39 36 75 
% within Death 100.0% 100.0% 100.0% 
Pearson Chi-Square=6.490* p=0.011 
 
Mortality in patients with ARF 
 
 
In our study Acute Renal Failure showed statistically significant relation 
to mortality. Mortality is increased in patients with renal failure. 
75% of the non-survivors had acute renal failure. 
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Crosstab 
 
Sepsis Type 
Total 
Septic shock Severe sepsis 
ARF 
absent 
Count 9 21 30 
% within 
Sepsis_Type 
23.1% 58.3% 40.0% 
present 
Count 30 15 45 
% within 
Sepsis_Type 
76.9% 41.7% 60.0% 
Total 
Count 39 36 75 
% within 
Sepsis_Type 
100.0% 100.0% 100.0% 
Pearson Chi-Square=9.696* p=0.002 
 
 
 
 
The percentage of renal failure increased with the severity of sepsis.  
In our study 41.7% of patients with severe sepsis and 76.9 % with septic 
shock presented with acute renal failure 
 
Microbiological Charecteristics of  patients  
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Blood Culture and Sensitivity 
 
Blood Culture Frequency Percent 
Negative 60 80.0 
Positive 15 20.0 
Total 75 100.0 
 
 
 
 
 
Among the 75 patients in our population only 20% of the subjects 
showed positive blood culture  
Blood culture was negative in the remaining 80% of the population  
80%
20%
Blood Culture
Negative
Positive
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Crosstab 
 Death Total 
no yes 
Blood 
Culture 
negativ 
Count 35 25 60 
% within Death 89.7% 69.4% 80.0% 
positive 
Count 4 11 15 
% within Death 10.3% 30.6% 20.0% 
Total 
Count 39 36 75 
% within Death 100.0% 100.0% 100.0% 
Pearson Chi-Square=0.214 p=0.644 
 
There was no statistically significant relationship between blood 
culture positivity and mortality in our study  
The mortality didnt increase with blood culture positivity 
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Blood Culture   
No growth 60 80.0 
Acinetobacter 4 5.3 
E. coli 2 2.7 
Enterobacter 1 1.3 
Klebsiella 3 4.0 
Pseudomonas 3 4.0 
Staph species 2 2.7 
Total 75 100.0 
 
 
 
 
 
In our study Acinetobacter species was the most common organism 
causing bacteremia and sepsis  followed by Pseudomonas and Klebsiella 
species 
Gram Negative Septicemia was most common in our study 
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URINE CULTURE 
Urine Culture Frequency Percent 
No growth 62 82.7 
Acinetobacter 3 4.0 
E. coli 8 10.7 
Klebsiella 2 2.7 
Total 75 100.0 
 
 
 
 
 
In our study, Urosepsis is the second most common source of infection  
About 18% of the study population showed positive urine culture 
E.coli was the most common organism isolated from urine samples 
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SPUTUM CULTURE 
 
Sputum Culture Frequency 
No growth/ Non-respiratory infection 53 
Acinetobacter 7 
E. coli 1 
Klebsiella 6 
Pseudomonas 8 
Total 75 
 
 In our study, Respiratory tract was the most common source of 
infection leading to sepsis in  elderly. 
Pseudomonas followed by Acinetobacter species were the most 
common organisms isolated from respiratory speimens. 
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CULTURE  POSITIVITY 
Crosstab 
 
Death 
Total 
no yes 
Culture 
Positivity 
negativ 
Count 20 12 32 
% within Death 51.3% 33.3% 42.7% 
positive 
Count 19 24 43 
% within Death 48.7% 66.7% 57.3% 
Total 
Count 39 36 75 
% within Death 100.0% 100.0% 100.0% 
Pearson Chi-Square=2.465 p=0.116 
 
In our study there is no statistically significant relation between 
culture positivity and mortality and patients with culture positivity was 
seen in 66.7% of non-survivors and 48.7% of survivors. 
Crosstab 
 
Sepsis_Type 
Total septic 
shock 
severe 
sepsis 
Culture 
Positivity 
negativ 
Count 15 17 32 
% within Sepsis 
Type 
38.5% 47.2% 42.7% 
positive 
Count 24 19 43 
% within Sepsis 
Type 
61.5% 52.8% 57.3% 
Total 
Count 39 36 75 
% within Sepsis 
Type 
100.0% 100.0% 100.0% 
Pearson Chi-Square=0.587 p=0.443 
 
There is no significant difference in severity of sepsis based on 
culture positivity. 
In patients with severe sepsis 52.3% showed culture positivity and 
in patients with sepic shock 61.5 % showed culture positivity, 
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PROCALCITONIN 
Crosstab 
 
Procalcitonin(Pct) 
Total 
2-10 10-30 >30 
Death 
Yes 
Count 3 24 9 36 
% within 
Pct 
10.0% 66.7% 100.0% 48.0% 
No 
Count 27 12 0 39 
% within 
Pct 
90.0% 33.3% 0.0% 52.0% 
Total 
Count 30 36 9 75 
% within 
Pct 
100.0% 100.0% 100.0% 100.0% 
Pearson Chi-Square=32.131** P<0.001 
 
 
In our study serum procalcitonin was significantly raised in 
patients with severe sepsis and septic shock .Increased serum 
procalcitonin was strongly related to mortality . The relation between 
serum procalcitonin and mortality was statistically significant.  
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Pearson Chi-Square=20.713** P<0.001 
  
There is a significant rise in serum procalcitonin based on the 
severity of sepsis, patients with septic shock showing a higher level of 
procalcitonin compared to those with severe sepsis 
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Crosstab 
 
Procalcitonin(Pct) 
Total 
2-10 10-30 >30 
Type of 
Sepsis 
severe 
sepsis 
Count 24 9 3 36 
% within Pct 80.0% 25.0% 33.3% 48.0% 
sepsis 
shock 
Count 6 27 6 39 
% within Pct 20.0% 75.0% 66.7% 52.0% 
Total 
Count 30 36 9 75 
% within Pct 100.0% 100.0% 100.0% 100.0% 
80 
 
Comparison of all the variables by survivor and non survivor 
Death N Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
t value p value 
Age 
no 39 69.18 7.99 1.28 
3.259** 0.002 
yes 36 76.36 10.97 1.83 
Temp 
no 39 100.67 1.42 0.23 
1.256 0.212 
yes 36 101.08 1.41 0.24 
MAP 
no 39 79.31 7.76 1.24 
5.771** p<0.001 
yes 36 69.67 6.60 1.10 
TC 
no 39 17.14 3.94 0.63 
1.937 0.057 
yes 36 18.92 4.01 0.67 
Platelets 
no 39 1.95 1.13 0.18 
1.812 0.074 
yes 36 1.55 0.69 0.12 
Urea 
no 39 56.46 20.87 3.34 
4.352** p<0.001 
yes 36 94.75 50.49 8.42 
Creatne 
no 39 2.03 0.73 0.12 
4.533** p<0.001 
yes 36 3.03 1.14 0.19 
PT 
no 39 13.67 2.51 0.40 
4.926** p<0.001 
yes 36 17.22 3.66 0.61 
RBS 
no 39 171.08 59.63 9.55 
1.923 0.058 
yes 36 212.67 120.04 20.01 
Ph 
no 39 7.34 0.09 0.01 
1.822 0.072 
yes 36 7.31 0.03 0.01 
HCO3 
no 39 23.41 4.02 0.64 
1.819 0.073 
yes 36 21.67 4.27 0.71 
Albumin 
no 39 3.05 0.30 0.05 
0.918 0.361 
yes 36 2.98 0.37 0.06 
CRP 
no 39 18.38 10.40 1.67 
0.368 0.714 
yes 36 19.25 9.95 1.66 
ESR 
no 39 23.59 15.65 2.51 
1.718 0.09 
yes 36 31.42 23.33 3.89 
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Procalcitonin 
no 39 8.87 3.89 0.62 
7.872** p<0.001 
yes 36 23.66 11.02 1.84 
APACHE 
no 39 16.62 4.18 0.67 
15.678** p<0.001 
yes 36 29.33 2.60 0.43 
SOFA 
no 39 4.23 1.69 0.27 
14.253** p<0.001 
yes 36 11.58 2.70 0.45 
Hospital_Stay 
no 39 12.62 4.59 0.74 
9.071** p<0.001 
yes 36 5.00 2.15 0.36 
ICU_Stay 
no 39 4.46 1.23 0.20 
4.263** p<0.001 
yes 36 3.33 1.04 0.17 
 
 
Increase in age above 70 showing increased risk of mortality 
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The Mean Arterial Pressure was significantly low in non-survivors 
when compared to survivors 
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The increase in renal parameters was associated with increase in 
death rate. 
 
 
Increase in mortality seen with increase in Prothrombin Time 
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Procalcitonin is significantly raised in non-survivors when 
compared to survivors 
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Baseline APACHE II and SOFA Scores were significantly higher 
in non-survivors 
The survivors were mostly of young old age group. With 
increasing age mortality also has raised significantly. The Mean Arterial 
Pressure was significantly low in non-survivors with significant incidence 
of renal dysfunction.Renal Parameters (Urea and Creatinine) and 
Prothrombin Time were also significantly raised in non-survivors.The 
baseline scores used to predict severity of illness(APACHE II and SOFA 
Scores) were significantly higher in non-survivors. Procalcitonin, a 
biomarker is significantly raised in non-survivors when compared to 
survivors. Other markers of sepsis like Total Leukocyte Count, ESR and 
CRP didn’t show any significance between survivors and non-survivors 
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DISCUSSION 
        Inspite of the advances in medical science and antibiotic therapy 
sepsis proves to be a major cause of  morbidity and mortality in elderly. 
There are only few studies based on the usefulness of procalcitonin in 
elderly with sepsis. Our  study evaluated the significance of procalcitonin 
as a biomarker of sepsis in hospitalised elderly and compared it with 
other conventional markers of sepsis.  
In our study the mortality due to sepsis was 48 % which was 
consistent with the previous studies including a study by Jain et al(1,2,3). In 
our study , respiratory  tract  was the most common source of sepsis 
followed by urinary tract  which may be partly due to presence of risk 
factors like diabetes(4). Culture positivity is seen in 57.3 % of patients 
which is consistent with previous reports(9), but lower values has also 
been reported(3,10). Blood culture positivity was seen in 20% of the 
patients. The most common microorganism isolated being  Acinetobactor 
followed by Pseudomonas and Klebsiella, majority of them being gram 
negative. Culture positivity didnot predict prognosis or mortality in our 
study. This is similar to the findings in previous studies which didnot 
establish relation between culture positivity and mortality(5,7). 
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Our study showed significant increase in serum procalcitonin in 
elderly patients with sepsis, proving its utility as a marker of sepsis,which 
is consistent with the previous study by Chivate et al(12,13). In our study 
serum procalcitonin on admission was markedly elevated in non-
survivors, showing correlation between serum procalcitonin and 
mortality. This is comparable with the previous studies by Meng et al and 
Clec’h et al (13,14) ,whereas some studies didnt find procalcitonin to predict 
mortality(15,16). The variation may be due to the fact that our study was 
conducted in an exclusively medical setup excluding surgical and trauma 
cases which are believed to show spurious rise in procalcitonin level, also 
majority of the organisms isolated in our study were gram negative. A 
gram negative septicaemia is believed to have significant correlation with 
serum procalcitonin levels(17,18). Several studies have shown the 
significance of procalcitonin in predicting  prognosis in sepsis 
patients(15,19,20). In our study serum procalcitonin level tends to rise with 
severity of sepsis and organ dysfunction which is consistent with the 
findings reported by Giamarellos-Baorboulis et al(21).  
 All the variables were compared including the regular markers of 
sepsis, sepsis prognostic scoring systems and biomarkers  like CRP and 
Procalcitonin. 
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Both the survivors and non-survivors were similar in most of the 
characteristics except that the survivors were mostly of young old age 
group. With increasing age mortality also had raised significantly. The 
baseline severity of illness scores like APACHE II and SOFA Scores 
were significantly higher in non-survivors.  
Procalcitonin  is significantly raised in non-survivors when 
compared to survivors whereas other markers of sepsis like Total 
Leukocyte Count, ESR and CRP didn’t show any significant correlation 
between survivors and non-survivors. 
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LIMITATIONS 
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LIMITATIONS 
 
1. Single Centre Study 
 
2. Small sample size of 75 patients 
 
3. Study period was only 6 months  
 
4. No control group 
 
5. Most of the patients were taking antibiotics prior to admission 
 
6. Presence of preexisting organ dysfunction in older population 
 
7. Serum levels of  Procalcitonin was measured only on admission 
and was not repeated at regular intervals. 
 
8. Due to cost restrains more inflammatory markers couldn’t be tested 
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CONCLUSION 
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CONCLUSION 
 Procalcitonin test, as a biomarker of  sepsis has greater value 
in detecting patients with sepsis. 
 Its of greater significance also in elderly population with 
sepsis but test results should always be interpreted in 
conjunction with clinical findings. 
 Increased procalcitonin level at admission is a better 
predictor of organ dysfunction and mortality  in elderly 
patients and its prognostic value in elderly patients is much 
better when compared to other markers of sepsis including 
CRP. 
  Further randomised control study on procalcitonin and non-
procalcitonin monitored patients is needed to conclude if 
outcome and cost benefits increase with procalcitonin use. 
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PROFORMA 
 
NAME  SERIAL NO.  
AGE  DATE OF 
ADMISSION 
 
SEX  DATE OF 
DISCHARGE 
 
EDUCATIO
N 
 DURATION OF 
HOSPITAL STAY 
 
OCCUPATI
ON 
 CONTACT 
INFORMATION 
 
  
CHIEF 
COMPLAIN
TS 
 
 
 
 
  
CO 
MORBIDITIES 
YE
S 
N
O 
DURATI
ON 
 
 
SMOKING 
NEVER  
SYSTEMIC 
HYPERTENSIO
N 
   PAST  
DIABETES 
MELLITUS 
   
CURRE
NT 
 
DYSLIPIDEMIA    
ALCOHOL
ISM 
NEVER  
COPD/BRONCH
IAL ASTHMA 
   PAST  
CHRONIC 
KIDNEY 
DISEASE 
   
CURRE
NT 
 
CAD    
TOBACCO 
CHEWER 
YES/NO  
OTHER CVS 
DISEASES 
   
OTHER 
SUBSTANC
E 
ABUSE 
  
OLD CVA    
Others    
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GLASGOW 
COMA 
SCALE 
 
TEMPERATU
RE 
 
RESPIRATOR
Y RATE 
 
PULSE RATE  
BLOOD 
PRESSURE 
SYSTOLI
C BP 
 WITH INOTROPIC 
SUPPORT 
 
DIASTOLI
C BP 
 WITHOUT INOTROPHIC 
SUPPORT 
 
MAP    
 
APACHE SCORE   
SOFA      SCORE   
 
Investigations 
Complete Blood Count 
Hemoglobin  
Total count  
Differential count 
Polymorphs  
Lymphocytes  
Mixed   
Erythrocyte 
sedimentation rate 
 
Platelets  
 
Culture & 
Sensitivity 
 
Blood C/S  
Urine C/S  
Sputum C/S  
Pus/Wound C/S   
Serum 
Procalcitonin 
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C-Reactive 
Protein 
 
 
 
Supportive 
measures 
 
Inotropes  
Mechanical 
Ventilation 
 
 
 
Outcome  
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INFORMATION SHEET 
We are conducting a study titled “PROCALCITONIN AS A 
MARKER OF SEPSIS IN HOSPITALISED ELDERLY” among 
patients attending Rajiv Gandhi Government General Hospital, Chennai 
and for that your specimen may be valuable to us. 
The purpose of this study is to estimate the significance of 
procalcitonin as a diagnostic and prognostic marker of sepsis in elderly 
population. 
We are selecting certain cases and if you are found eligible, we 
may be using your blood, sputum and urine samples to do special studies 
which in any way do not affect your final report or management. 
The privacy of the patients in the research will be maintained 
throughout the study. In the event of any publication or presentation 
resulting from the research, no personally identifiable information will be 
shared. 
Taking part in this study is voluntary. You are free to decide 
whether to participate in this study or to withdraw at any time; your 
decision will not result in any loss of benefits to which you are otherwise 
entitled. 
The results of the special study may be intimated to you at the end 
of the study period or during the study if anything is found abnormal 
which may aid in the management or treatment. 
 
Signature of investigator                          Signature of participant 
 
Date:  
Place: . 
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PATIENT CONSENT FORM 
 
 
Study Detail      :  Procalcitonin as a Marker of Sepsis in  
   Hospilasied Elderly 
 
Study Centre     :  Rajiv Gandhi Govt. General Hospital, Chennai. 
 
Patient’s Name     : 
 
Patient’s Age      :  
 
Identification No.  : 
 
Patient may check           these boxes: 
 
• I confirm that I have understood the purpose of procedure for the 
above study.  
I have the opportunity to ask question and all my questions and 
doubts have been answered to my  complete satisfaction. 
 
• I understand that my participation in the study is voluntary and 
that I am free to withdraw at any time without giving reason, 
without my legal rights being affected. 
 
• I understand that sponsor of the clinical study, others working on 
the sponsor’s behalf, the ethical committee and the regulatory 
authorities will not need my permission to look at my health 
records, both in respect of current study and any further research 
that may be conducted in relation to it, even if I withdraw from 
the study I agree to this access. However, I understand that my 
identity will not be revealed in any information released to third 
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parties or published, unless as required under the law. I agree not 
to restrict the use of any data or results that arise from this study. 
• I agree to take part in the above study and to comply with the 
instructions given during the study and faithfully cooperate with 
the study team and to immediately inform the study staff if I 
suffer from any deterioration in my health or wellbeing or any 
unexpected or unusual symptoms. 
• I hereby consent to participate in this study. 
• I hereby give permission to undergo complete clinical 
examination, blood investigations, sputum, urine tests and Chest 
X-Ray 
 
 
 
 
 
 
Signature / Thumb Impression   Signature of Investigator 
 
 
Patient’s Name & Address:    Study Investigator’s Name : 
                                                                                 Dr. FLORA ALEX 
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Age Sex Temp MAP TC Platelets Urea Creat AKI PT RBS Ph HCO3 Albumin CRP ESR
Procalcito
nin
APACHE SOFA
C/S 
Positivity
Blood C/S 
Positivity
Mortality
101 M 100.2 83 16 0.72 28 1.4 Absent 11.3 206 7.33 23.2 2.9 16 10 6.5 25 7 Positive Positive Dead
75 M 103 93 18 1.78 44 1.1 Absent 11.6 154 7.42 30.6 3.3 15 12 2.9 12 3 Ngative Negative Alive
66 M 101.4 70 17.2 2.32 98 2.9 Present 11.4 326 7.3 29 3.4 30 24 13.8 28 13 Negative Negative Dead
73 M 99.6 77 19.1 1.05 44 1.8 Absent 19.3 110 7.28 25.4 2.8 21 32 20.34 30 9 Positive Negative Dead
83 F 103.2 75 26.2 0.95 56 1.6 Absent 12.6 138 7.29 21.6 2.6 8 10 10.53 32 14 Negative Negative Dead
71 F 104 73 24.2 1.54 122 2.5 Present 17.8 524 7.31 28 3.1 14 88 38.16 31 10 Positive Negative Dead
61 M 101.6 83 16.3 1.86 92 2.8 Present 13.4 214 7.31 20.5 3.4 11 22 5.33 18 5 Negative Negative Alive
63 M 99.2 93 13.2 0.75 38 1.2 Absent 18.3 178 7.34 23.4 2.7 25 18 9.1 11 3 Positive Positive Alive
68 M 100.6 73 18.2 2.45 89 3.1 Present 15.6 302 7.27 18.8 3.5 42 34 4.87 13 6 Negative Negative Alive
86 F 102.2 73 13.6 0.64 58 1.6 Absent 11.8 115 7.37 22.9 2.8 9 10 6.92 17 2 Positive Negative Alive
81 F 100.4 81 15.4 0.89 40 1.8 Absent 16.2 100 7.41 16.4 3 12 44 6.27 21 4 Negative Negative Alive
64 F 104 87 12.9 3.14 77 2.6 Present 10.6 92 7.29 26.3 2.9 21 8 7.51 16 3 Positive Negative Alive
69 M 100 70 21.2 4.65 29 1.3 Absent 12.4 245 7.4 26.4 3.1 23 20 9.19 14 2 Positive Negative Alive
67 F 104 73 20 3.21 34 1.2 Absent 10.8 136 7.34 27.1 3 9 8 8.42 16 4 Positive Positive Alive
62 F 103 80 25 2.94 42 2.3 Present 13.1 196 7.36 24.8 2.8 11 12 16.71 27 8 Negative Negative Alive
94 M 101.2 69 18.3 0.59 89 2.4 Present 18.5 213 7.32 26 3.4 42 74 26.7 30 11 Positive Negative Dead
88 M 102.6 65 14.1 1.64 68 2.9 Present 17.9 138 7.28 24 2.5 13 48 43.81 27 16 Positive Negative Dead
69 M 99.6 57 19.8 0.94 109 4.2 Present 21.4 245 7.33 22.8 2.7 9 26 28.17 34 13 Negative Negative Dead
71 M 100.2 67 15.6 2.05 232 3.6 Present 18.6 156 7.3 28 3.3 22 14 35.54 28 8 Positive Positive Dead
91 F 100.6 68 14.5 2.14 114 4.5 Present 22.1 102 7.31 20.9 2.4 15 17 19.4 29 12 Negative Negative Dead
63 F 99.9 63 23.5 1.85 99 5.1 Present 15.1 296 7.25 24.5 3.5 30 21 23.32 32 15 Positive Negative Dead
78 F 100.5 69 20.2 2.85 78 3.4 Present 20.6 98 7.29 26.2 3.1 11 33 17.63 26 11 Positive Positive Dead
62 M 102 75 20 0.86 48 1.8 Absent 11.3 122 7.38 24.4 2.7 36 15 14.74 14 6 Negative Negative Alive
77 M 99.8 80 20.32 2.96 69 2.4 Present 15.4 161 7.4 17.4 3.6 16 60 10.31 17 5 Positive Negative Alive
64 F 103 70 13.1 3.15 74 3.2 Present 17.2 209 7.43 25.3 2.8 9 9 12.98 20 4 Positive Negative Alive
98 M 100.2 83 11 0.72 28 1.4 Absent 11.3 206 7.33 23.2 2.9 16 10 6.5 25 7 Positive Positive Dead
75 M 100.1 93 26.1 1.78 44 1.1 Absent 11.6 154 7.42 30.6 3.3 15 12 2.9 12 3 Negative Negative Alive
65 M 101.4 70 17.2 2.32 98 2.9 Present 11.4 326 7.3 19.1 3.4 30 24 13.8 28 13 Negative Negative Dead
73 M 99.6 77 19.1 1.05 44 1.8 Absent 19.3 110 7.28 25.4 2.8 21 32 20.34 30 9 Positive Negative Dead
83 F 103.2 75 26.2 0.95 56 1.6 Absent 12.6 138 7.29 21.6 2.6 8 10 10.53 32 14 Positive Positive Dead
71 F 104 73 24.2 1.54 122 2.5 Present 17.8 524 7.31 18 3.1 14 88 38.16 31 10 Positive Negative Dead
61 M 101.6 83 26.1 1.24 92 2.8 Present 13.4 214 7.26 20.5 3.4 11 30 5.33 18 5 Negative Negative Alive
63 M 99.2 93 18.56 0.75 38 1.2 Absent 18.3 178 7.3 23.4 2.7 25 32 9.1 11 3 Positive Positive Alive
68 M 100.6 73 20.9 1.45 89 3.1 Yes 15.6 302 7.22 18.8 3.5 42 34 4.87 13 6 Negative Negative Alive
86 F 102.2 73 18.4 0.64 58 1.6 Present 11.8 115 7.1 22.9 2.8 9 30 6.92 17 2 Positive Negative Alive
83 F 100.4 81 15.4 0.89 40 1.8 Absent 16.2 100 7.2 16.4 3 12 44 6.27 21 4 Negative Negative Alive
64 F 98.8 87 20.9 1.14 77 2.6 Present 10.6 92 7.12 26.3 2.9 21 36 7.51 16 3 Positive Negative Alive
69 M 99.8 70 21.2 1.43 29 1.3 Absent 12.4 245 7.1 26.4 3.1 23 20 9.19 14 2 Negative Negative Alive
67 F 99.6 73 21.24 1.21 34 1.2 Absent 10.8 136 7.34 27.1 3 9 42 8.42 16 4 Positive Negative Alive
61 F 100.6 80 14.2 2.94 42 2.3 Present 13.1 196 7.36 24.8 2.8 11 12 16.71 27 8 Negative Negative Alive
69 M 101.2 69 18.3 0.59 89 2.4 Present 18.5 213 7.32 12.6 3.4 42 74 26.7 30 11 Positive Negative Dead
88 M 102.6 65 14.1 1.64 68 2.9 Present 17.9 138 7.4 15.2 2.5 13 48 43.81 27 16 Negative Negative Dead
69 M 99.6 57 19.8 0.94 109 4.2 Present 21.4 245 7.33 22.8 2.7 9 26 28.17 34 13 Negative Negative Dead
71 M 100.2 67 15.6 2.05 232 3.6 Present 18.6 156 7.3 18.4 3.3 22 14 35.54 28 8 Positive Positive Dead
73 F 100.6 68 14.5 2.14 114 4.5 Present 22.1 102 7.31 20.9 2.4 15 17 19.4 29 12 Negative Negative Dead
63 F 99.9 63 23.5 1.85 99 5.1 Present 15.1 296 7.4 16.8 3.5 30 21 23.32 32 15 Positive Negative Dead
78 F 100.5 69 20.2 2.85 78 3.4 Present 20.6 98 7.29 26.2 3.1 11 33 17.63 26 11 Positive Positive Dead
62 M 99.6 75 16.7 0.86 48 1.8 Absent 11.3 122 7.38 24.4 2.7 36 15 14.74 14 6 Negative Negative Alive
77 M 99.8 80 15.3 1.96 69 2.4 Present 15.4 161 7.4 17.4 3.6 16 60 10.31 17 5 Positive Negative Alive
64 F 99.4 70 13.1 1.15 74 3.2 Present 17.2 209 7.43 25.3 2.8 9 9 12.98 20 4 Positive Negative Alive
99 M 100.2 83 16 0.72 28 1.4 Absent 11.3 206 7.33 23.2 2.9 16 10 6.5 25 7 Positive Positive Dead
75 M 100.1 93 12 1.78 44 1.1 Absent 11.6 154 7.42 30.6 3.3 15 12 2.9 12 3 Negative Negative Alive
66 M 101.4 70 17.2 2.32 98 2.9 Present 11.4 326 7.3 19.1 3.4 30 12 13.8 28 13 Negative Negative Dead
73 M 99.6 77 19.1 1.05 44 1.8 Absent 19.3 110 7.28 25.4 2.8 21 12 20.34 30 9 Positive Negative Dead
83 F 103.2 75 26.2 0.95 56 1.6 Absent 12.6 138 7.29 21.6 2.6 8 10 10.53 32 14 Negative Negative Dead
71 F 104 73 24.2 1.54 122 2.5 Present 17.8 524 7.31 18 3.1 14 60 38.16 31 10 Positive Positive Dead
61 M 101.6 83 16.3 1.86 92 2.8 Present 13.4 214 7.31 20.5 3.4 11 22 5.33 18 5 Negative Negative Alive
63 M 99.2 93 13.2 0.75 38 1.2 Absent 18.3 178 7.34 23.4 2.7 25 18 9.1 11 3 Positive Positive Alive
68 M 100.6 73 18.2 2.45 89 3.1 Present 15.6 302 7.27 18.8 3.5 42 34 4.87 13 6 Negative Negative Alive
86 F 102.2 73 13.6 0.64 58 1.6 Absent 11.8 115 7.37 22.9 2.8 9 10 6.92 17 2 Positive Negative Alive
81 F 100.4 81 15.4 0.89 40 1.8 Absent 16.2 100 7.41 16.4 3 12 44 6.27 21 4 Negative Negative Alive
64 F 98.8 87 12.9 3.14 77 2.6 Present 10.6 92 7.29 26.3 2.9 21 8 7.51 16 3 Positive Negative Alive
69 M 99.8 70 21.2 4.65 29 1.3 Absent 12.4 245 7.4 26.4 3.1 23 20 9.19 14 2 Negative Negative Alive
67 F 99.6 73 11 3.21 34 1.2 Absent 10.8 136 7.34 27.1 3 9 8 8.42 16 4 Positive Negative Alive
62 F 100.6 80 14.2 2.94 42 2.3 Present 13.1 196 7.36 24.8 2.8 11 12 16.71 27 8 Negative Negative Alive
78 M 101.2 69 18.3 0.59 89 2.4 Present 18.5 213 7.32 12.6 3.4 42 74 26.7 30 11 Positive Negative Dead
88 M 102.6 65 14.1 1.64 68 2.9 Present 17.9 138 7.28 15.2 2.5 13 48 43.81 27 16 Positive Negative Dead
69 M 99.6 57 19.8 0.94 109 4.2 Present 21.4 245 7.33 22.8 2.7 9 26 28.17 34 13 Negative Negative Dead
71 M 100.2 67 15.6 2.05 232 3.6 Present 18.6 156 7.3 18.4 3.3 22 14 35.54 28 8 Positive Positive Dead
61 F 100.6 68 14.5 2.14 114 4.5 Present 22.1 102 7.31 20.9 2.4 15 17 19.4 29 12 Negative Negative Dead
63 F 99.9 63 23.5 1.85 99 5.1 Present 15.1 296 7.25 16.8 3.5 30 21 23.32 32 15 Positive Negative Dead
78 F 100.5 69 20.2 2.85 78 3.4 Present 20.6 98 7.29 26.2 3.1 11 33 17.63 26 11 Positive Positive Dead
62 M 99.6 75 16.7 0.86 48 1.8 Absent 11.3 122 7.38 24.4 2.7 36 15 14.74 14 6 Negative Negative Alive
77 M 99.8 80 15.3 2.96 69 2.4 Present 15.4 161 7.4 17.4 3.6 16 60 10.31 17 5 Positive Negative Alive
64 F 99.4 70 13.1 3.15 74 3.2 Present 17.2 209 7.43 25.3 2.8 9 9 12.98 20 4 Positive Negative Alive
